Atavir Capsule 300 mg | Atazanavir | HIV Treatment

Introduction of Atavir Capsule 300 mg

Atavir 300 mg Capsule is a prescription antiretroviral medication used for the effective treatment and management of HIV-1 (Human Immunodeficiency Virus type 1) infection. It contains the active ingredient Atazanavir, which belongs to the class of drugs called protease inhibitors. Atavir is typically used in combination with other antiretroviral agents to help control HIV infection, boost immune function, and reduce the risk of developing AIDS and related complications.

✅ Key Benefits of Atavir 300 mg:

• Potent viral suppression when used with other antiretrovirals
  
  

• Improves CD4+ T-cell counts
  
  

• Helps prevent HIV-related complications and opportunistic infections
  
  

• Convenient once-daily dosing
  
  

• Well-tolerated with a favorable side effect profile
  
  

✅ Precautions & Warnings:

• Not recommended for patients with severe liver disease
  
  

• May cause changes in liver function, bilirubin levels, and lipid profile
  
  

• Inform your doctor if you are taking other medications due to potential drug interactions
  
  

• Use with caution in individuals with heart rhythm abnormalities (QT prolongation)
  
  

• Regular ECG, liver tests, and blood monitoring are advised
  
  

✅ Possible Side Effects:

Common side effects:

• Nausea
  
  

• Headache
  
  

• Jaundice (yellowing of eyes or skin)
  
  

• Diarrhea
  
  

• Abdominal pain
  
  

Less common but serious:

• Hepatitis or liver toxicity
  
  

• Allergic reactions
  
  

• Kidney stones
  
  

• Heart rhythm disturbances
  
  

✅ Storage Instructions:

• Store at room temperature below 30°C
  
  

• Keep away from moisture and direct sunlight
  
  

• Store in a secure place, out of reach of children
  
  

Atavir 300 mg is an essential component in modern HIV treatment regimens, offering reliable suppression of the virus when used as part of combination therapy. With consistent use, it can improve quality of life and long-term health outcomes for people living with HIV.